Detalles de la búsqueda
1.
The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
Hum Brain Mapp
; 42(17): 5736-5746, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34510640
2.
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
Alzheimers Dement
; 16(10): 1358-1371, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573951
3.
Influence of vascular imaging acquisition at local stroke centers on workflows in the drip-n-ship model: a RACECAT post hoc analysis.
J Neurointerv Surg
; 16(2): 143-150, 2024 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068936
4.
Tipping the scales: how clinical assessment shapes the neural correlates of Parkinson's disease mild cognitive impairment.
Brain Imaging Behav
; 16(2): 761-772, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34553331
5.
Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and ß-amyloid?
Alzheimers Res Ther
; 14(1): 126, 2022 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068641
6.
Genetic Influences on Hippocampal Subfields: An Emerging Area of Neuroscience Research.
Neurol Genet
; 7(3): e591, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34124350
7.
Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
J Alzheimers Dis
; 84(1): 119-128, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34569957
8.
Cognitively unimpaired individuals with a low burden of Aß pathology have a distinct CSF biomarker profile.
Alzheimers Res Ther
; 13(1): 134, 2021 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34315519
9.
Amyloid-ß positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume.
Neurobiol Aging
; 104: 24-31, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33962331
10.
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
Alzheimers Res Ther
; 13(1): 46, 2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33597012
11.
CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
Neurology
; 97(21): e2065-e2078, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34556565
12.
Sex Differences of Longitudinal Brain Changes in Cognitively Unimpaired Adults.
J Alzheimers Dis
; 76(4): 1413-1422, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32651319
13.
Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4.
Alzheimers Dement (Amst)
; 12(1): e12127, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33204815
14.
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aß pathology are detected.
EMBO Mol Med
; 12(12): e12921, 2020 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33169916
Resultados
1 -
14
de 14
1
Próxima >
>>